Navigating India's Evolving Landscape: From Policy Shifts to Health Crises and Innovation Dreams The Betrayal in the Therapy Room: When 'Wellness' Meant Fentanyl AbbVie's High-Stakes Forecast: A Boost That Still Left the Market Wanting More Regeneron's Remarkable Q3: A Dupixent-Driven Triumph That Reaffirms Biotech's Pulse